{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:52:04Z","timestamp":1791229924478,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejso.2020.06.018","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T02:38:48Z","timestamp":1592447928000},"page":"2195-2201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: The SUNRISE study"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0035-0679","authenticated-orcid":false,"given":"Isabel T.","family":"Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rodriguez-Revuelto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4293-3875","authenticated-orcid":false,"given":"Martin","family":"Espinosa-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Siso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3126-2623","authenticated-orcid":false,"given":"Joaquin","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Esgueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejso.2020.06.018_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A\u00a0randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ejso.2020.06.018_bib2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.06.018_bib3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0002-9610(98)00264-5","article-title":"Sentinel lymph node biopsy for staging breast cancer","volume":"176","author":"Rubio","year":"1998","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2020.06.018_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2020.06.018_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10434-001-0013-9","article-title":"Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures","volume":"8","author":"Cody","year":"2001","journal-title":"Ann Surg Oncol"},{"issue":"22","key":"10.1016\/j.ejso.2020.06.018_bib6","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.1996.03540220042028","article-title":"Lymphatic mapping and sentinel node biopsy in the patient with breast cancer","volume":"276","author":"Albertini","year":"1996","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.ejso.2020.06.018_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cncr.21568","article-title":"Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis","volume":"106","author":"Kim","year":"2006","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2020.06.018_bib8","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/S1470-2045(13)70590-4","article-title":"Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review","volume":"15","author":"Ahmed","year":"2014","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.06.018_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejso.2010.12.007","article-title":"Sentinel lymph node biopsy in early breast cancer surgery--working with the risks of vital blue dye to reap the benefits","volume":"37","author":"White","year":"2011","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.06.018_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1245\/s10434-015-4809-4","article-title":"Evaluation of the clinical utility of the ICG fluorescence method compared with the radioisotope method for sentinel lymph node biopsy in breast cancer","volume":"23","author":"Sugie","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.06.018_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejso.2014.11.006","article-title":"The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer","volume":"41","author":"Rubio","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.06.018_bib12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1148\/radiology.175.2.2326475","article-title":"Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging","volume":"175","author":"Weissleder","year":"1990","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ejso.2020.06.018_bib13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1245\/s10434-013-3379-6","article-title":"Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial","volume":"21","author":"Douek","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.06.018_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.breast.2014.01.004","article-title":"The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope","volume":"23","author":"Thill","year":"2014","journal-title":"Breast"},{"issue":"8","key":"10.1016\/j.ejso.2020.06.018_bib15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ejso.2015.04.017","article-title":"Superparamagnetic iron oxide as a tracer for sentinel node biopsy in breast cancer: a comparative non-inferiority study","volume":"41","author":"Pinero-Madrona","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.06.018_bib16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jso.24164","article-title":"Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: the French Sentimag feasibility trial","volume":"113","author":"Houpeau","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.06.018_bib17","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1245\/s10434-016-5135-1","article-title":"Use of a magnetic tracer for sentinel lymph node detection in early-stage breast cancer patients: a meta-analysis","volume":"23","author":"Teshome","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.06.018_bib18","article-title":"The superparamagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment","volume":"26","author":"Ghilli","year":"2017","journal-title":"Eur J Canc Care"},{"issue":"2","key":"10.1016\/j.ejso.2020.06.018_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10549-016-3809-9","article-title":"The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies","volume":"157","author":"Karakatsanis","year":"2016","journal-title":"Breast Canc Res Treat"},{"issue":"11","key":"10.1016\/j.ejso.2020.06.018_bib20","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1245\/s10434-019-07577-4","article-title":"SentimagIC: a non-inferiority trial comparing superparamagnetic iron oxide versus technetium-99m and blue dye in the detection of axillary sentinel nodes in patients with early-stage breast cancer","volume":"26","author":"Alvarado","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.06.018_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"J\u00a0Am Med Assoc"},{"issue":"5","key":"10.1016\/j.ejso.2020.06.018_bib22","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1245\/s10434-019-07239-5","article-title":"Long-term outcome after retro-areolar versus peri-tumoral injection of superparamagnetic iron oxide nanoparticles (SPIO) for sentinel lymph node detection in breast cancer surgery","volume":"26","author":"Warnberg","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.06.018_bib23","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00000658-199906000-00013","article-title":"Subareolar versus peritumoral injection for location of the sentinel lymph node","volume":"229","author":"Klimberg","year":"1999","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2020.06.018_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejso.2017.11.016","article-title":"Feasibility of breast MRI after sentinel procedure for breast cancer with superparamagnetic tracers","volume":"44","author":"Krischer","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.018_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejro.2019.05.006","article-title":"Improvement in breast magnetic resonance imaging after a sentinel procedure for breast cancer with superparamagnetic tracers","volume":"6","author":"Forte","year":"2019","journal-title":"Eur J Radiol Open"},{"issue":"17","key":"10.1016\/j.ejso.2020.06.018_bib26","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1200\/JCO.18.02092","article-title":"Prospective, multicenter, randomized phase III trial evaluating the impact of lymphoscintigraphy as part of sentinel node biopsy in early breast cancer: SenSzi (GBG80) trial","volume":"37","author":"Kuemmel","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2020.06.018_bib27","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1245\/s10434-018-6616-1","article-title":"Patient-reported outcomes for breast cancer","volume":"25","author":"Tevis","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.06.018_bib28","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/jso.25012","article-title":"Breast-specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: results from the randomized COBALT study","volume":"117","author":"Volders","year":"2018","journal-title":"J\u00a0Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320305424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320305424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:35:26Z","timestamp":1760060126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320305424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0748798320305424"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.06.018","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: The SUNRISE study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}